Tapentadol, Urine, Quantitative
Also known as: TAPENTA UR
Use
This test is used to quantify Tapentadol in urine, primarily for medical purposes and not for forensic use. It is useful in evaluating compliance and appropriate administration of Tapentadol. The absence of expected drug levels might indicate non-compliance, inappropriate timing of specimen collection, poor drug absorption, diluted/adulterated urine, or testing limitations. The results assist physicians in managing patient therapy and monitoring drug levels within therapeutic limits.
Special Instructions
The test is a preferred method for follow-up on presumptive results. For general screening purposes, the Tapentadol Urine Screen with Reflex to Quantitation is recommended instead. The test is a Laboratory Developed Test (LDT) and has not been FDA-approved.
Limitations
The test cannot be used for forensic purposes. Limitations include potential for non-compliance detection, inappropriate timing of specimen collection relative to drug administration, and challenges like diluted or adulterated urine that might affect Tapentadol detection. The result of 'negative' does not guarantee the absence of drug due to these limitations.
New York Approved
Methodology
Mass Spectrometry
Biomarkers
LOINC Codes
- 65807-0
Result Turnaround Time
1-8 days
Related Documents
For more information, please review the documents below
Specimen
Urine
Volume
2 mL
Minimum Volume
1 mL
Container
ARUP standard transport tube
Collection Instructions
Transfer urine with no additives or preservatives to the transport tube.
Storage Instructions
Refrigerated storage is required.
Causes for Rejection
Repeated freeze/thaw cycles.
Stability Requirements
| Temperature | Period |
|---|---|
| Room Temperature | 1 week |
| Refrigerated | 1 month |
| Frozen | 3 years |